Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease (AD), and its pathogenesis remains obscure. Current treatment …

Ginger is composed of multiple bioactive compounds, including 6-gingerol, 6-shogaol, 10-
gingerol, gingerdiones, gingerdiols, paradols, 6-dehydrogingerols, 5-acetoxy-6-gingerol, 3 …

Age-related neurological disorders (ANDs), including neurodegenerative diseases, are
multifactorial disorders with a risk that increases with aging. ANDs are generally …

Alzheimer's disease (AD) is a neurodegenerative condition mostly communal in people of
advanced years accompanying various dysfunctionalities especially cognitive impairments …

Parkinson's disease (PD) is the second most common neurodegenerative disease with a
fast-growing prevalence. Developing disease-modifying therapies for PD remains an …

Parkinson's disease (PD), one of the most common neurological diseases worldwide, is
mainly characterized neuropathologically by the dopaminergic neurodegeneration in the …

The current pharmacological treatment for Parkinson's disease (PD) is focused on symptom
alleviation rather than disease prevention. In this study, we look at a new strategy to …

Aim: 6-Shogaol [1-(4-hydroxy-methoxyphenyl)-4-decen-one], a pungent compound isolated
from ginger, has shown various neurobiological and anti-inflammatory effects. The aim of …

Parkinson's disease (PD) is a progressive neurodegenerative disorder, whose treatment
with modern therapeutics leads to a plethora of side effects with prolonged usage …

Parkinson's disease (PD) which has various pathological mechanisms, recently, it is
attracting attention to the mechanism via microbiome-gut-brain axis. 6-Shogaol, a …